These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 34931675)

  • 21. Cost-benefit analysis of a strategy to vaccinate healthy working adults against influenza.
    Nichol KL
    Arch Intern Med; 2001 Mar; 161(5):749-59. PubMed ID: 11231710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.
    Forbes C; Shirran L; Bagnall AM; Duffy S; ter Riet G
    Health Technol Assess; 2001; 5(28):1-110. PubMed ID: 11701100
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Costs and effectiveness of influenza vaccination: a systematic review.
    D'Angiolella LS; Lafranconi A; Cortesi PA; Rota S; Cesana G; Mantovani LG
    Ann Ist Super Sanita; 2018; 54(1):49-57. PubMed ID: 29616674
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence base of economic evaluations of workplace-based interventions reducing occupational sitting time: an integrative review.
    Akhavan Rad S; Kiwanuka F; Korpelainen R; Torkki P
    BMJ Open; 2022 Jun; 12(6):e060139. PubMed ID: 35772822
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating costs and health consequences of sick leave strategies against pandemic and seasonal influenza in Norway using a dynamic model.
    Edwards CH; Tomba GS; Sonbo Kristiansen I; White R; de Blasio BF
    BMJ Open; 2019 Apr; 9(4):e027832. PubMed ID: 30948617
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Cost-effectiveness of vaccines for the prevention of seasonal influenza in different age groups: a systematic review].
    Valcárcel Nazco C; García Lorenzo B; Del Pino Sedeño T; García Pérez L; Brito García N; Linertová R; Ferrer Rodríguez J; Imaz Iglesia I; Serrano Aguilar P
    Rev Esp Salud Publica; 2018 Oct; 92():. PubMed ID: 30327454
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Scoping Review of Economic Evaluations of Workplace Wellness Programs.
    Unsal N; Weaver G; Bray J; Bibeau D
    Public Health Rep; 2021; 136(6):671-684. PubMed ID: 33541206
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effectiveness and cost-effectiveness of ehealth interventions in somatic diseases: a systematic review of systematic reviews and meta-analyses.
    Elbert NJ; van Os-Medendorp H; van Renselaar W; Ekeland AG; Hakkaart-van Roijen L; Raat H; Nijsten TE; Pasmans SG
    J Med Internet Res; 2014 Apr; 16(4):e110. PubMed ID: 24739471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving influenza vaccination rates in the workplace: a randomized trial.
    Nowalk MP; Lin CJ; Toback SL; Rousculp MD; Eby C; Raymund M; Zimmerman RK
    Am J Prev Med; 2010 Mar; 38(3):237-46. PubMed ID: 20036102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost-Effectiveness Analyses of Digital Health Technology for Improving the Uptake of Vaccination Programs: Systematic Review.
    Wang Y; Fekadu G; You JH
    J Med Internet Res; 2023 May; 25():e45493. PubMed ID: 37184916
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial.
    Bridges CB; Thompson WW; Meltzer MI; Reeve GR; Talamonti WJ; Cox NJ; Lilac HA; Hall H; Klimov A; Fukuda K
    JAMA; 2000 Oct; 284(13):1655-63. PubMed ID: 11015795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cost-Benefit Evaluation of an Organizational-Level Intervention Program for Decreasing Sickness Absence among Public Sector Employees in Sweden.
    Severin J; Svensson M; Akerstrom M
    Int J Environ Res Public Health; 2022 Mar; 19(5):. PubMed ID: 35270691
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health-Related Workplace Absenteeism Among Full-Time Workers - United States, 2017-18 Influenza Season.
    Groenewold MR; Burrer SL; Ahmed F; Uzicanin A; Luckhaupt SE
    MMWR Morb Mortal Wkly Rep; 2019 Jul; 68(26):577-582. PubMed ID: 31269013
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cost benefit of influenza vaccination in healthy, working adults: an economic analysis based on the results of a clinical trial of trivalent live attenuated influenza virus vaccine.
    Nichol KL; Mallon KP; Mendelman PM
    Vaccine; 2003 May; 21(17-18):2207-17. PubMed ID: 12706712
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B.
    Turner D; Wailoo A; Nicholson K; Cooper N; Sutton A; Abrams K
    Health Technol Assess; 2003; 7(35):iii-iv, xi-xiii, 1-170. PubMed ID: 14609480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of Productivity Loss/Gain in Cost-Effectiveness Analyses for Drugs: A Systematic Review.
    Yuasa A; Yonemoto N; LoPresti M; Ikeda S
    Pharmacoeconomics; 2021 Jan; 39(1):81-97. PubMed ID: 33230613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sickness absence due to influenza.
    O'Reilly FW; Stevens AB
    Occup Med (Lond); 2002 Aug; 52(5):265-9. PubMed ID: 12181375
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of influenza on working days lost: a review of the literature.
    Keech M; Beardsworth P
    Pharmacoeconomics; 2008; 26(11):911-24. PubMed ID: 18850761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic impact of providing workplace influenza vaccination. A model and case study application at a Brazilian pharma-chemical company.
    Burckel E; Ashraf T; de Sousa Filho JP; Forleo Neto E; Guarino H; Yauti C; Barreto F de B; Champion L
    Pharmacoeconomics; 1999 Nov; 16(5 Pt 2):563-76. PubMed ID: 10662481
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.